85 results
Page 2 of 5
6-K
EX-5.1
zo1r5l
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-1.1
ol21s 2tpi1
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
0jtyb8
10 Feb 21
Prospectus supplement for primary offering
5:22pm
F-3MEF
EX-5.1
al6et9l6
9 Feb 21
Registration statement to add securities to prior F-3 registration
9:40pm
424B5
fc0ocb 42
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
3nc7a
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-5.1
lnboo
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
21eqj tovl25
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-99.2
2ed1u8lw le8wa
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-99.1
jvcu9lqby1mh44de6mc
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-4.1
pucib1ov6swf7z
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
5fcavxm857iv8aqz
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-5.1
2ea 2370batj
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-4.2
m6z3rfpplbed7p5gh
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
4nuq7n8ms7q13l 13b1
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-4.1
hqk74
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm